Join

Compare · HUM vs SERA

HUM vs SERA

Side-by-side comparison of Humana Inc. (HUM) and Sera Prognostics Inc. (SERA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HUM and SERA operate in Medical Specialities (Health Care), so they compete in similar markets.
  • HUM is the larger of the two at $42.03B, about 468.7x SERA ($89.7M).
  • SERA has been more active in the news (9 items in the past 4 weeks vs 4 for HUM).
  • HUM has more recent analyst coverage (25 ratings vs 8 for SERA).
MetricHUMSERA
Company
Humana Inc.
Sera Prognostics Inc.
Price
$355.91+1.64%
$2.13-6.99%
Market cap
$42.03B
$89.7M
1M return
+43.90%
-
1Y return
+52.72%
-
Industry
Medical Specialities
Medical Specialities
Exchange
NYSE
NASDAQ
IPO
2021
News (4w)
4
9
Recent ratings
25
8
HUM

Humana Inc.

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.

SERA

Sera Prognostics Inc.

Sera Prognostics, Inc., a health diagnostic company, discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. It develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Latest HUM

Latest SERA